Libya vs North Macedonia: Expected share of deaths from non-communicable diseases
Libya
19.8%
in 2021
North Macedonia
19.6%
in 2021
Libya rank
87th
North Macedonia rank
89th
Expected share of deaths from non-communicable diseases over time
- Libya
- North Macedonia
How they compare
Libya currently reports 19.8% against 19.6% in North Macedonia, a difference of 0.2%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was North Macedonia ahead.
Libya ranks 87th and North Macedonia ranks 89th of 185 countries.
Across the 3 decades both report, Libya averaged higher in 1 and North Macedonia in 2.
Head to head by decade
| Decade | Libya | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.7% | 24.6% | 3.8% | North Macedonia |
| 2010s | 20.4% | 21.1% | 0.8% | North Macedonia |
| 2020s | 20.2% | 19.7% | 0.5% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected share of deaths from non-communicable diseases, Libya or North Macedonia?
- Libya, at 19.8% against 19.6% in North Macedonia as of 2021.
- What is the difference in expected share of deaths from non-communicable diseases between Libya and North Macedonia?
- 0.2%, with Libya ahead.
- How many years of comparable data are there for Libya and North Macedonia?
- 22 years are reported by both, from 2000 to 2021.
- How do Libya and North Macedonia rank globally for expected share of deaths from non-communicable diseases?
- Libya ranks 87th and North Macedonia ranks 89th of 185 countries.
- Where does this data come from?
- World Health Organization (WHO), Global Health Observatory, via World Bank (2026) – processed by Our World in Data, published as Expected share of deaths from non-communicable diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.